<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04369339</url>
  </required_header>
  <id_info>
    <org_study_id>OHRHPVCOLP</org_study_id>
    <nct_id>NCT04369339</nct_id>
  </id_info>
  <brief_title>Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology</brief_title>
  <official_title>Immediate Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Abnormal cervical cytology was the most common reason for women being referred to the
      colposcopy unit. We prospectively included the women with negative cytology (negative for
      intraepithelial lesions or malignancy (NILM)) and positive High RiskHPV test other than HPV
      16 or HPV 18. Comparing the immediate colposcopy findings among women with High Risk HPV
      other than HVPV16/18 and negative cytology and determine positive predictive values for CIN2+
      of other high risk HPV genotypes
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2015</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective cohort study comparing the immediate colposcopy findings among women with HrHPV other than HVPV16/18 and negative cytology</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>outcomes assessor blind to clinical data and cytology results</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Dysplasia</measure>
    <time_frame>1 month</time_frame>
    <description>Pathologic diagnosis of cervical dysplasia</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">185</enrollment>
  <condition>Human Papillomavirus Infection</condition>
  <arm_group>
    <arm_group_label>Other High Risk HPV Positivity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Colposcopy performed to women with High risk HPV positive ,negative for intraepithelial lesions or malignancy cytology</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HPV16/18</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Colposcopy performed to women with HPV 16/18 positive ,negative for intraepithelial lesions or malignancy cytology</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Colposcopy</intervention_name>
    <arm_group_label>HPV16/18</arm_group_label>
    <arm_group_label>Other High Risk HPV Positivity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  negative cytology (negative for intraepithelial lesions or malignancy (NILM)) and
             positive HrHPV test other than HPV 16 or HPV 18

        Exclusion Criteria:

          -  Previous diagnosis for cervical cancer Previous diagnosis for vaginal cancer Previous
             diagnosis for cervical dysplasia Previous diagnosis for ASCUS previous history of
             cervical conisation or hysterectomy previous history ofhysterectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 28, 2020</study_first_submitted>
  <study_first_submitted_qc>April 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2020</study_first_posted>
  <last_update_submitted>April 28, 2020</last_update_submitted>
  <last_update_submitted_qc>April 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bezmialem Vakif University</investigator_affiliation>
    <investigator_full_name>Serdar AydÄ±n</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <keyword>Human Papilloma Virus</keyword>
  <keyword>negative for intraepithelial lesions or malignancy</keyword>
  <keyword>HPV16</keyword>
  <keyword>HPV18</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Papillomavirus Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

